Here’s What Varian Medical Systems’ Valuation Trend Indicates



Analyst recommendations

In August, nine analysts are covering Varian Medical Systems (VAR) stock. Three of them have given the stock a “strong buy” rating, three have given it a “hold,” and three have given it a “sell.” The mean rating for VAR stock is 2.67 with a target price of $122. That implies an upside potential of 9.1% over its closing price of $111.83 on August 20.

Article continues below advertisement

Peer ratings

In comparison, peers Stryker (SYK), Accuray (ARAY), Medtronic (MDT), and PerkinElmer (PKI) have mean ratings of 1.97, 2.86, 2.24, and 2.5, respectively. Their target prices are $183.93, $7.20, $95.55, and $87.25, respectively.

Valuation metrics

So far in 2018, Varian Medical Systems stock has fluctuated from $110.98 on January 2 to a high of $130.29 on January 26. After that, it has gradually corrected to the current level of $112.

The enterprise value of Varian Medical Systems is $9.66 billion, and its enterprise-value-to-revenue ratio is 3.35. The stock is trading at a forward price-to-earnings multiple of 23.30x. Its price-to-sales ratio is 3.56, and its price-to-book ratio is 6.86.

Its current ratio, a metric of how effectively a company can meet its short-term obligations, is 1.60. Its return on equity stands at 9.89%. In comparison, the returns on equity for peers Stryker (SYK), Medtronic (MDT), and PerkinElmer (PKI) are 11.08%, 6.12%, and 6%, respectively.


More From Market Realist